Zhejiang Shouxiangu Pharmaceutical Co., Ltd.

SSE:603896.SS

22.31 (CNY) • At close June 6, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024202320222021202020192018201720162015201420132012
Revenue 691.684784.347829.072767.137636.051546.759511.452369.963314.88301.912301.592253.03177.753
Cost of Revenue 133.347135.528129.207126.373105.67285.40772.06350.92947.57657.46782.15387.86176.385
Gross Profit 558.336648.819699.864640.765530.379461.352439.389319.035267.304244.446219.439165.169101.368
Gross Profit Ratio 0.8070.8270.8440.8350.8340.8440.8590.8620.8490.810.7280.6530.57
Reseach & Development Expenses 36.59749.68347.82450.82548.48539.41933.66720.96917.8117.94820.5512.7019.002
General & Administrative Expenses 37.68643.93237.1935.67244.99458.97753.09418.38812.44512.01113.91133.1123.373
Selling & Marketing Expenses 229.484316.794319.375319.757264.018233.653236.499178.564138.793128.065103.8472.71644.735
SG&A 267.17360.726356.565355.429309.012292.63289.593196.952151.238140.076117.751105.82668.108
Other Expenses 79.305-58.15628.11634.55516.68415.318-0.217-2.0469.945.2593.2322.3694.102
Operating Expenses 383.073394.097432.505440.809374.181347.367339.957233.312191.366181.084155.423107.37468.96
Operating Income 175.263254.722280.878207.153158.904127.774110.30590.83771.01257.49566.44652.65130.83
Operating Income Ratio 0.2530.3250.3390.270.250.2340.2160.2460.2260.190.220.2080.173
Total Other Income Expenses Net -0.5360.189-2.913-6.093-5.202-2.78-0.217-2.0469.945.1273.0832.3692.489
Income Before Tax 174.727254.911277.966201.061153.702124.994110.08888.79180.92762.62369.52955.0234.898
Income Before Tax Ratio 0.2530.3250.3350.2620.2420.2290.2150.240.2570.2070.2310.2170.196
Income Tax Expense 0.0130.4310.4530.7491.991.0992.435-0.089-0.051-0.0210.2780.9720.875
Net Income 174.715254.48277.783200.827151.712123.895107.65388.8880.97862.64469.25154.04834.023
Net Income Ratio 0.2530.3240.3350.2620.2390.2270.210.240.2570.2070.230.2140.191
EPS 0.881.31.441.040.820.680.590.550.590.460.510.40.32
EPS Diluted 0.881.31.441.040.820.680.580.550.590.460.510.40.32
EBITDA 268.489379.576372.706278.359220.733175.668158.288131.162202.54598.5487.54660.97533.671
EBITDA Ratio 0.3880.4840.450.3630.3470.3210.3090.3550.6430.3260.290.2410.189